^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ifabotuzumab (KB004)

    i
    Other names: KB004 , KB-004
    Company:
    Humanigen, Olivia Newton-John Cancer Research Institute
    Drug class:
    EPH receptor inhibitor, EphA3 inhibitor
    Related drugs: